What’s happening
ResMed is supporting 18 clinical study abstracts presented at the ATS 2022 International Conference. Research expands our knowledge of:
- Obstructive sleep apnea (OSA) patient management
- COPD patient management, links between COPD, other diseases
- Asthma patient management (including pediatric asthma)
- Global smoking prevalence
When: Saturday, May 13–Wednesday, May 18, 2022
Where: The Moscone Center | 747 Howard St, San Francisco, CA 94103
Available for interviews:
- Adam Benjafield, PhD; VP, Medical Affairs, ResMed
- Meredith Barrett, PhD; VP, Medical Affairs, ResMed
- Atul Malhotra, MD; Research Chief of Pulmonary, Critical Care, and Sleep
Medicine, University of California San Diego
To schedule interviews:
- Kristin Deuber, +1 614.975.4186, resmed@allisonpr.com
Abstracts (complete list, by topic):
| Topic | Subject | Date/Time | Location |
| OSA | Lipid mgmt. in patients w/ OSA, coronary artery disease | May 15, 2:15-3:45p | Room 2022/2024 |
| When to intervene: PAP users with OSA, comorbidities* | May 16, 9:30-11a | Room 303-304 |
| Heart risk in patients w/ OSA, acute coronary syndrome | May 16, 9:30-11a | Room 303-304 |
| AirSense 11: User experience on ResMed’s new PAP* | May 16, 11:15a-1:15p | Hall F, Area A |
| PAP use of patients remotely diagnosed and managed** | May 16, 11:15a-1:15p | Hall F, Area A |
| Predicting PAP users’ healthcare resource utilization* | May 16, 2:15-3:45p | Room 2022/2024 |
| Blood pressure variability during PAP withdrawal | May 16, 2:15-3:45p | Room 2022/2024 |
| OSA’s and PAP’s effects on ACS patients’ blood pressure | May 17, 9:30-9:40a | Room 3014 |
| PAP’s effects on cognition, mild cognitive impairment | May 18, 9:05-9:15a | Room 2006/2008 |
| PAP dose-response relationship with clinical outcomes | May 18, 9:15-9:25a | Room 2006/2008 |
| Healthy-user effect in PAP-adherent in people with OSA* | May 18, 9:25-9:35a | Room 2006/2008 |
| COPD | Early detection of COPD exacerbations | May 15, 11:15a-1:15p | Hall F, Area C |
| Prevalence of comorbidities in adults with COPD* | May 18, 8:15-9:45a | Room 303-304 |
| Asthma | Prevalence of comorbidities in adults with asthma* | May 15, 11:15a-1:15p | Hall F, Area C |
| Validation of wearable to monitor children* | May 15, 11:15a-1:15p | Hall F, Area E |
| Financial incentives to improve adolescent adherence | May 16, 9:30-11a | Room 2005/2007 |
| Self-reported vs. digitally captured inhaler use data* | May 17, 2:15-3:45p | Room 3016/3018 |
| Smoking | Global projections of smoking prevalence trends* | May 15, 9:30-11a | Room 303-304 |
* Presented by a ResMed employee; others presented by non-ResMed key opinion leaders
** Presented by Primasun, a joint venture between ResMed and Verily, an Alphabet company
# # #